Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $2.11 Million - $2.51 Million
-17,263 Reduced 57.59%
12,714 $1.65 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $197,837 - $237,663
-1,615 Reduced 5.11%
29,977 $3.72 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $301,187 - $360,736
2,248 Added 7.66%
31,592 $4.62 Million
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $320,797 - $395,309
-2,473 Reduced 7.77%
29,344 $4.67 Million
Q3 2022

Feb 14, 2023

SELL
$126.59 - $161.18 $797,137 - $1.01 Million
-6,297 Reduced 16.52%
31,817 $4.24 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $797,137 - $1.01 Million
-6,297 Reduced 16.52%
31,817 $4.24 Million
Q2 2022

Feb 14, 2023

SELL
$141.59 - $168.66 $1.93 Million - $2.29 Million
-13,598 Reduced 26.3%
38,114 $5.95 Million
Q2 2022

Aug 15, 2022

SELL
$141.59 - $168.66 $1.93 Million - $2.29 Million
-13,598 Reduced 26.3%
38,114 $5.95 Million
Q1 2022

Feb 14, 2023

BUY
$129.64 - $160.7 $2.58 Million - $3.2 Million
19,895 Added 62.53%
51,712 $8.05 Million
Q1 2022

May 13, 2022

SELL
$129.64 - $160.7 $14.4 Million - $17.8 Million
-110,815 Reduced 68.18%
51,712 $8.05 Million
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $8.29 Million - $10.1 Million
-69,198 Reduced 29.86%
162,527 $20.7 Million
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $1.87 Million - $2.69 Million
14,538 Added 6.69%
231,725 $30.2 Million
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $4.13 Million - $4.8 Million
25,774 Added 13.47%
217,187 $38.6 Million
Q1 2021

May 14, 2021

BUY
$150.19 - $173.5 $4.13 Million - $4.78 Million
27,527 Added 16.8%
191,413 $31.5 Million
Q4 2020

Feb 12, 2021

SELL
$140.71 - $165.05 $276,917 - $324,818
-1,968 Reduced 1.19%
163,886 $27 Million
Q3 2020

Nov 13, 2020

SELL
$105.46 - $144.13 $594,161 - $812,028
-5,634 Reduced 3.29%
165,854 $23.6 Million
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $981,772 - $1.25 Million
10,261 Added 6.36%
171,488 $18.9 Million
Q1 2020

May 15, 2020

BUY
$87.74 - $152.74 $742,368 - $1.29 Million
8,461 Added 5.54%
161,227 $16.1 Million
Q4 2019

Feb 18, 2020

BUY
$117.65 - $153.73 $81,531 - $106,534
693 Added 0.46%
152,766 $22.8 Million
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $2.58 Million - $2.95 Million
-20,597 Reduced 11.93%
152,073 $19.5 Million
Q2 2019

Aug 13, 2019

SELL
$125.55 - $144.48 $3.05 Million - $3.51 Million
-24,287 Reduced 12.33%
172,670 $24.6 Million
Q1 2019

May 14, 2019

BUY
$121.81 - $142.95 $1.3 Million - $1.53 Million
10,703 Added 5.75%
196,957 $28.2 Million
Q4 2018

Feb 13, 2019

BUY
$115.94 - $166.74 $3.97 Million - $5.71 Million
34,225 Added 22.51%
186,254 $23.1 Million
Q3 2018

Nov 08, 2018

BUY
$161.01 - $180.57 $268,725 - $301,371
1,669 Added 1.11%
152,029 $25.6 Million
Q2 2018

Aug 13, 2018

BUY
$146.33 - $183.18 $7.49 Million - $9.37 Million
51,169 Added 51.59%
150,360 $25.9 Million
Q1 2018

May 14, 2018

BUY
$135.59 - $157.16 $1.52 Million - $1.76 Million
11,222 Added 12.76%
99,191 $15 Million
Q4 2017

Feb 13, 2018

SELL
$131.06 - $150.39 $3.79 Million - $4.35 Million
-28,893 Reduced 24.72%
87,969 $11.8 Million
Q3 2017

Nov 13, 2017

BUY
$142.62 - $155.6 $16.7 Million - $18.2 Million
116,862
116,862 $17.1 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.